Huntsworth plc announced the acquisition of New York-based AboveNation Media LLC, adding to its collection of leading health, wellness and lifestyle marketing companies under Evoke Group.
The world’s largest diabetes drugmaker, Novo Nordisk, presented the first successful data from a large final-stage study of a pill the company hopes will transform the diabetes market.
A vast research study that sought to settle a long-standing debate about whether or not anti-depressant drugs really work has found they are indeed effective in relieving acute depression in adults.
An advisory committee of the U.S. CDC recommended the use of AstraZeneca’s FluMist Quadrivalent vaccine in the upcoming flu season, reversing its earlier position.
A new chief executive officer and a fresh infusion of $50 million in Series C funding has given ORIC Pharmaceuticals Inc. a shot in the arm as the South San Francisco-based company continues to push development of its lead asset for treatment-resistant cancers.
The U.S. FDA granted San Diego-based Evofem Biosciences Fast Track designation for Amphora vaginal gel to prevent urogenital chlamydia infection in women.
AbbVie and Neurocrine Biosciences’ Phase III ELARIS UF-1 clinical trial of elagolix for uterine fibroids hit its primary endpoint.
Fast Company recently published The World’s 50 Most Innovative Companies 2018, topping off its edition of the top 350 most innovative companies. Here is a look at the life science companies that made the list.
Merck & Co. is driving forward in its quest to develop a premier immuno-oncology pipeline with the acquisition of Australia-based Viralytics Ltd. and its oncolytic immunotherapy treatments.
Inception Digital – the premiere broadcast production and delivery company – announced the introduction of Pando, a groundbreaking meeting platform that enables face-to-face collaboration delivered remotely.
Ashfield, part of UDG Healthcare, a global leader in providing outsourced healthcare services, announced the launch of a pioneering new commercial model called The Ashfield Solution.
Heart devices that use software or wireless communications may be vulnerable to hacker attacks that could cause life-threatening malfunctions, U.S. cardiologists say.
People who try to avoid junk food may lose similar amounts of weight on a low-carb or low-fat diet even when their genetics suggest that one of these options should be better for them.
Nevada-based PDL BioPharma will no longer pursue a proposed acquisition of Neos Therapeutics. PDL made three failed attempts to acquire Texas-based Neos.
Chicago-based AbbVie and Cambridge, Mass.-based Voyager Therapeutics inked a collaboration deal to develop treatments for Alzheimer’s disease and other neurodegenerative diseases.
The U.S. government proposed extending the availability of skimpy health insurance plans to millions of Americans in another Trump administration move aimed at undercutting the requirements of the Affordable Care Act, often called Obamacare.
U.S. drug developer Aimmune Therapeutics Inc.’s peanut allergy drug met the main goal of an eagerly awaited late-stage study.
Wave Life Sciences and Takeda Form Global Strategic Collaboration to Advance Therapies for Central Nervous System Disorders
Wave Life Sciences Ltd. announced the formation of a global strategic collaboration with Takeda Pharmaceutical Company Ltd. to discover, develop and commercialize nucleic acid therapies for disorders of the central nervous system.
Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases
Shire, Microsoft and EURORDIS-Rare Diseases Europe announced a strategic alliance to address the diagnostic challenge for patients living with a rare disease.
Eli Lilly and its Korean collaborative partner Hanmi Pharmaceutical stopped a Phase II trial on an experimental rheumatoid arthritis treatment after less-than-stellar interim results were examined.